{"id":442,"date":"2018-03-09T16:48:57","date_gmt":"2018-03-09T21:48:57","guid":{"rendered":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma.png"},"modified":"2022-02-07T15:09:09","modified_gmt":"2022-02-07T20:09:09","slug":"generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma","status":"inherit","type":"attachment","link":"https:\/\/www.lifetein.com\/blog\/personalized-treatment-using-synthetic-peptides\/generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma\/","title":{"rendered":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma"},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"class_list":["post-442","attachment","type-attachment","status-inherit","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\n","aioseo_head_json":{"title":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma | LifeTein Peptide Blog","description":"personalized medicine using synthetic peptides","canonical_url":"https:\/\/www.lifetein.com\/blog\/personalized-treatment-using-synthetic-peptides\/generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"xKDW6DUiGuZ6nwglNeWlVWTgzTtMPzas13ROL63ytTc","msvalidate.01":"5B15601215D876311F84CFEFB0F72F18","miscellaneous":""},"schema":null,"og:locale":"en_US","og:site_name":"LifeTein Peptide Synthesis Blog","og:type":"article","og:title":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma | LifeTein Peptide Blog","og:description":"personalized medicine using synthetic peptides","og:url":"https:\/\/www.lifetein.com\/blog\/personalized-treatment-using-synthetic-peptides\/generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma\/","fb:admins":"233983946638783","og:image":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2020\/02\/LifeTein-Blog1-2-scaled.jpg","og:image:secure_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2020\/02\/LifeTein-Blog1-2-scaled.jpg","article:published_time":"2018-03-09T21:48:57+00:00","article:modified_time":"2022-02-07T20:09:09+00:00","article:publisher":"https:\/\/www.facebook.com\/LifeTein-LLC-233983946638783\/","twitter:card":"summary_large_image","twitter:site":"@lifetein","twitter:title":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma | LifeTein Peptide Blog","twitter:description":"personalized medicine using synthetic peptides","twitter:creator":"@lifetein","twitter:image":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2020\/02\/LifeTein-Blog1-2-scaled.jpg"},"aioseo_meta_data":{"post_id":"442","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"none","priority":null,"frequency":null,"location":null,"local_seo":null,"seo_analyzer_scan_date":null,"breadcrumb_settings":null,"limit_modified_date":false,"open_ai":null,"ai":null,"created":"2020-12-04 22:27:49","updated":"2025-06-18 01:54:53"},"aioseo_breadcrumb":"
\n\t\t\tHome<\/a>\n\t\t<\/span>»<\/span>\n\t\t\tGeneration-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.lifetein.com\/blog"},{"label":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma","link":"https:\/\/www.lifetein.com\/blog\/personalized-treatment-using-synthetic-peptides\/generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma\/"}],"filename":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma.png","filesize":213401,"description":{"rendered":"

\"personalized<\/a><\/p>\n

personalized medicine using synthetic peptides<\/p>\n"},"caption":{"rendered":"

personalized medicine using synthetic peptides Continue reading →<\/span><\/a><\/p>\n"},"alt_text":"personalized medicine using synthetic peptides","media_type":"image","mime_type":"image\/png","media_details":{"width":1132,"height":1446,"file":"2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma.png","sizes":{"thumbnail":{"file":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-150x150.png","width":150,"height":150,"filesize":15239,"mime_type":"image\/png","source_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-150x150.png"},"medium":{"file":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-235x300.png","width":235,"height":300,"filesize":44527,"mime_type":"image\/png","source_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-235x300.png"},"medium_large":{"file":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-768x981.png","width":768,"height":981,"filesize":378691,"mime_type":"image\/png","source_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-768x981.png"},"large":{"file":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-802x1024.png","width":802,"height":1024,"filesize":422538,"mime_type":"image\/png","source_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-802x1024.png"},"post-thumbnail":{"file":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-1000x288.png","width":1000,"height":288,"filesize":150021,"mime_type":"image\/png","source_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-1000x288.png"},"large-feature":{"file":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-1000x288.png","width":1000,"height":288,"filesize":150021,"mime_type":"image\/png","source_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-1000x288.png"},"small-feature":{"file":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-235x300.png","width":235,"height":300,"filesize":44527,"mime_type":"image\/png","source_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma-235x300.png"},"full":{"file":"Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma.png","width":1132,"height":1446,"mime_type":"image\/png","source_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma.png"}},"image_meta":{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0","keywords":[]},"filesize":213401},"post":441,"source_url":"https:\/\/www.lifetein.com\/blog\/wp-content\/uploads\/2018\/03\/Generation-of-a-personal-multi-peptide-neoantigen-vaccine-for-patients-with-high-risk-melanoma.png","_links":{"self":[{"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/media\/442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/comments?post=442"}],"wp:attached-to":[{"embeddable":true,"post_type":"post","id":441,"href":"https:\/\/www.lifetein.com\/blog\/wp-json\/wp\/v2\/posts\/441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}